Mr. Robert J. Decker Jr.

Controller & Chief Accounting Officer

Dr. Peter M. Fasolo Ph.D.

Executive Vice President & Chief HR Officer

Ms. Elizabeth  Forminard

Executive Vice President & Gen. Counsel

Mr. Alex  Gorsky

Executive Chairman

Mr. Joaquin  Duato

Chief Executive Officer & Chairman

Dr. Guy J. Lebeau M.D.

Group Chairman of MD&D Bus. - EMEA

Mr. Dirk  Brinckman

Chief Compliance Officer

Chief Executive Officer & Director

Mr. James  Swanson

Executive Vice President & Chief Information Officer

Ms. Jessica  Moore

Vice President of Investor Relations

Mr. Joseph J. Wolk C.P.A.

Executive Vice President & Chief Financial Officer

Ms. Ashley A. McEvoy

Executive Vice President & Worldwide Chairman of MedTech

Mr. Thibaut  Mongon

Executive Vice President & Worldwide Chairman of Consumer Health

Ms. Jennifer L. Taubert

Executive Vice President & Worldwide Chairman of Pharmaceuticals

Dr. John C. Reed M.D., Ph.D.

Executive Vice President of Pharmaceuticals R&D

Mr. Joseph J. Wolk CPA

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Eli Lilly has surpassed Johnson & Johnson in market cap for the first time, driven by LLY's breakthroughs in obesity and Alzheimer's treatments. JNJ features a relatively less sanguine pipeline and earnings outlook. With a reasonable valuation and solid dividend yield, the chart appears mildly bearish in my view.

Johnson & Johnson Relinquishes Top Spot To Eli Lilly, Shares Undervalued Amid Technical Risks

Now that Memorial Day is in the rearview mirror, investors are thinking about summer. This is historically a quieter time for markets.

3 Bargain Stocks to Buy in June Before They Bounce

The stock market has been led higher by just a handful of names so far this year. Unfortunately, that means many stocks have performed poorly vs.

3 Blue-Chip Stocks to Buy for 100% Returns

The stock market is finally giving us hope of better days ahead, with the U.S. debt ceiling debacle behind us. However, investors who are in it for the long-term understand that the market can be volatile, and it is important to pick companies that are stable and reliable.

The 3 Best Long-Term Dividend Stocks to Buy in June

Today, we will look at 5 dividend stocks that appear to be trading at intriguing valuations. 2 of the dividend stocks are healthcare giants with one offering reliable dividends and the other also offering strong dividend growth. The final two stocks discussed are more of a higher risk/low floor play with earnings multiples in the single digits.

5 Top Dividend Stocks For June 2023

Eli Lilly's Market Cap Could Surpass J&J's for First Time Since 1997

Stock Market News

J&J Prices Consumer Unit IPO at $22 a Share

J&J Consumer-Health Unit’s Listing to Test IPO Market

Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook

Johnson & Johnson Offers to Settle Talc Claims for $8.9 Billion 

Opioid Settlement Money Is Coming. Two Ohio Counties Differ on How to Spend It.

J&J’s Talc Bankruptcy Case Thrown Out by Appeals Court

J&J Gets Ready to Break Up With Tylenol

Johnson & Johnson Profit Falls 25%

Johnson & Johnson Guides Above Expectations for 2023

J&J Slashes Production of Its Covid-19 Vaccine

J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales

J&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 Billion

J&J's Deal for Abiomed Signals a New Focus 

Abiomed Stock Surges on Johnson & Johnson Takeover

Johnson & Johnson Isn’t Rushing Into M&A

J&J Earnings Top Estimates. The CFO Explains What Went Right. 

Band-Aid and Tylenol Company to Be Named Kenvue

Jurist Noted for Bankruptcy Expertise Will Weigh J&J Talc Appeal 

Johnson & Johnson Trims Full-Year Guidance on Stronger Dollar 

Johnson & Johnson Tops Profit Estimates but Trims Full-Year Outlook

IBM, Apple, JNJ, and More of Tuesday's Stock Market Movers

J&J Plans to End Covid-19 Vaccine Deal With Emergent BioSolutions

Covid-19 Vaccine and Drug Sales, Once Booming, Plateau 

J&J Names Executives of Tylenol, Band-Aid Company

FDA Limits Use of Johnson & Johnson’s Covid-19 Vaccine 

J&J Sues Drug-Benefit Middleman Over Drug-Cost Assistance Program

Johnson & Johnson Sues Alleged HIV-Drug Counterfeiters

Johnson & Johnson Backs Off Covid Vaccine Sales Guidance 

Johnson & Johnson Cuts Sales Guidance 

J&J Settles With West Virginia in Opioid Suit for $99 Million

Justice Department Probes Alleged Sales of Counterfeit HIV Drugs

FDA Approves Cell-Based Therapy for Blood Cancer Discovered in China

Johnson & Johnson, Drug Distributors Agree to Opioid Settlement With States

Judge Backs J&J’s Talc Bankruptcy, Keeping Cancer Lawsuits Frozen 

Native American Tribes Reach $590 Million Opioid Settlement

Johnson & Johnson Posts Higher Quarterly Sales Despite Some Pandemic-Related Pains

AMC, IBM, Microsoft, GE: What to Watch in the Stock Market Today

Barron’s 10 Stock Picks for 2022

Rivian, FedEx, Cerner, Oracle: What to Watch in the Stock Market Today

CDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’s

CDC Advisers: Use Pfizer, Moderna Vaccines Over J&J

An Exclusive Look at Merck’s Efforts to Help Make Rival J&J’s Covid Vaccine

J&J Prepares to Untangle Finances Ahead of Planned Split 

Fauci says changing fully vaccinated definition to include boosters 'on the table'

Omicron Variant Has Covid-19  Vaccine Makers Preparing for Worst Case 

Moderna, Coinbase, Occidental, Royal Caribbean: What to Watch in the Stock Market Today

J&J Covid-19 Vaccine Recipients Shift to Other Boosters

Most Vulnerable More at Risk of Breakthrough Hospitalization

What to Know About Johnson & Johnson’s Breakup 

Johnson & Johnson Breakup Is No Clean Sweep 

Johnson & Johnson to Split Consumer From Pharmaceutical, Medical-Device Businesses, Creating Two Companies

Rivian Automotive Stock Price: What to Watch in the Stock Market Today

J&J Split Sees Band-Aid, Tylenol Go Their Own Way

How Bankruptcy Could Help Johnson & Johnson Corral Vast Talc Litigation 

J&J Talc Bankruptcy Case Moved to New Jersey From North Carolina

Johnson & Johnson Opioid Verdict Overturned by Oklahoma Supreme Court

Vaccine Boosters’ Mix-and-Match Efficacy

Opioid Manufacturers Score Win in California Lawsuit

Moderna and J&J Covid-19 Booster Shots Backed by CDC

FDA Authorizes Covid-19 Vaccine Boosters From Moderna, J&J 

Johnson & Johnson’s Sales Climb Across Divisions

Johnson & Johnson’s Stock Deserves a Booster 

Dover, Procter & Gamble, Travelers, Netflix: What to Watch in the Stock Market Today

FDA Nears Approval for Mixing Covid-19 Booster Shots

Zillow, State Street, Valneva, Upstart: What to Watch in the Stock Market Today

J&J Covid-19 Booster Shot Endorsed by FDA Advisers 

Johnson & Johnson Puts Unit Holding Talc Claims Into Bankruptcy

J&J Booster Dose Bolsters Protection Against Covid-19, FDA Says 

J&J Booster Shot May Bolster Immune Response, FDA Says

Johnson & Johnson’s Top Scientist to Depart

Johnson & Johnson Asks FDA to Authorize Covid-19 Booster 

J&J: Booster Shot Works, but First Doses Are Effective

Moderna’s Covid-19 Shot Best Prevents Hospitalization, Study Indicates 

Covid-19 Vaccine Booster Launch Could Be Delayed for Many

Zoom Video, AMC, CrowdStrike: What to Watch When the Stock Market Opens Today

Covid-19 Vaccine Efficacy: What Do the Numbers Really Mean?

J&J Says Covid-19 Booster Prompts Strong Immune Response

J&J's Booster Shot Increases Antibodies

J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition.

As Delta Surges, Covid-19 Breakthrough Cases Remain Uncommon 

Vaccine Scammers Target Authorities in Dozens of Countries

FDA Moving Toward Decision Authorizing Booster Shot for Immunocompromised

Covid-19 Cases Are Still Rising, but the Vaccine News Is Promising

J&J Vaccine Highly Effective Against Delta Variant in South African Trial

U.S. Has Shared 110 Million Covid-19 Vaccine Doses Overseas

J&J Contractor Plans to Resume Covid-19 Vaccine Production at Troubled Plant

100 American athletes at the Tokyo Olympics are unvaccinated, team doctor says

Johnson & Johnson Posts Higher Quarterly Profit 

Coca-Cola, Johnson & Johnson, Chipotle: What to Watch When the Stock Market Opens Today

$26 Billion Opioid Settlement Expected This Week

Blackstone, AIG, NortonLifeLock, Morgan Stanley: What to Watch When the Stock Market Opens Today

Companies boast about big climate change pledges but less than 50% of the S&P 100 lobbies Washington accordingly

FDA Warns of New Rare Side Effect of J&J Vaccine

FDA Warns J&J Covid-19 Vaccine Raises Risk of Rare Neurological Condition 

J&J Vaccine Shows Promise Protecting Against Delta Variant 

Johnson & Johnson Settles New York Opioid Case for $230 Million 

Powered by AI

Johnson & Johnson

160.26